Mésusage de l'alcool. Dépistage, diagnostic et traitementRecommandation de bonne pratique, Alcoologie Addictologie, vol.37, issue.1, pp.5-84, 2015. ,
American Psychiatric Association explains DSM-5, BMJ, vol.346, p.3591, 2013. ,
The DSM-5: Classification and criteria changes, World Psychiatry, vol.12, issue.2, pp.92-98, 2013. ,
, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders : Fifth Edition, DMS Library, 2013.
, World Health Organization. International guide for monitoring alcohol consumption and related harm, 2000.
,
,
Alcool et santé : bilan et perspectives ,
La consommation d'alcool en France. Presse Médicale, vol.43, pp.1067-79, 2014. ,
Alcohol-attributable mortality in France, Eur J Public Health. 1 août, vol.23, issue.4, pp.588-93, 2013. ,
Numéro thématique-L'alcool, toujours un facteur de risque majeur pour la santé en France Special issue-Alcohol remains a major risk factor for health in France ,
,
Observatoire Français des Drogues et des Toxicomanies, Paris. FRA. Drogues, chiffres clés. 5e édition, p.8, 2013. ,
, All in for alcohol awareness, Lancet Lond Engl. 18 avr, vol.385, issue.9977, p.1477, 2015.
Prevalence of alcohol dependence among US adult drinkers, Prev Chronic Dis, vol.11, p.206, 2009. ,
, Observatoire Français des Drogues et des Toxicomanies. (O.F.D.T.). Paris. FRA. Drogues et addictions, données essentielles, p.399, 2013.
Concurrent brief versus intensive smoking intervention during alcohol dependence treatment, Psychol Addict Behav J Soc Psychol Addict Behav. déc, vol.21, issue.4, pp.570-575, 2007. ,
Smoking initiation among nonsmokers during and following treatment for alcohol use disorders, J Subst Abuse Treat. avr, vol.26, issue.3, pp.219-243, 2004. ,
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study, Drug Alcohol Depend. 1 juill, vol.103, issue.1-2, pp.30-36, 2009. ,
Improved drinking behaviour improves quality of life: a follow-up in alcohol-dependent subjects 7 years after treatment, Alcohol Alcohol, vol.48, issue.5, pp.579-84, 2013. ,
Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil. déc, vol.23, issue.10, pp.2757-67, 2014. ,
, Le Craving : approche transversale, dimensionnelle et translationnelle | Congrès Français de Psychiatrie
Neuroimaging of cocaine craving states: cessation, stimulant administration, and drug cue paradigms, Neuropsychopharmacol Fifth Gener Prog ACNP, vol.110, pp.1575-90, 2002. ,
Baclofen as a Cocaine Anti-Craving Medication: A Preliminary Clinical Study, Neuropsychopharmacology. mai, vol.18, issue.5, pp.403-407, 1998. ,
Baclofen attenuates the reinforcing effects of cocaine in rats, Neuropsychopharmacology, vol.15, issue.4, pp.417-440, 1996. ,
Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure, Psychopharmacology (Berl). juin, vol.131, issue.3, pp.271-278, 1997. ,
Brain activation in response to cravingand aversion-inducing cues related to alcohol in patients with alcohol dependence, Drug Alcohol Depend. 1 août, vol.141, pp.124-155, 2014. ,
The impact of atrial natriuretic peptide on anxiety, stress and craving in patients with alcohol dependence, Alcohol Alcohol. juin, vol.49, issue.3, pp.282-288, 2014. ,
Effects of adrenal sensitivity, stress-and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes, Arch Gen Psychiatry. sept, vol.68, issue.9, pp.942-52, 2011. ,
Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives, Alcohol Fayettev N, vol.43, issue.7, pp.559-63, 2009. ,
Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation, Biol Psychiatry, vol.76, issue.9, pp.734-775, 2014. ,
Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment, Alcohol Alcohol. août, vol.39, issue.4, pp.357-61, 2004. ,
Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician, Alcohol Alcohol. avr, vol.40, issue.2, pp.147-50, 2005. ,
La saga du baclofène et le changement de paradigme de la prise en charge de l'addiction à l'alcool. Presse Médicale, vol.45, pp.1117-1140, 2016. ,
Suppression of symptoms of alcohol dependence and craving using highdose baclofen, Alcohol Alcohol. avr, vol.42, issue.2, pp.158-60, 2007. ,
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial, Alcohol Alcohol. juin, vol.46, issue.3, pp.312-319, 2011. ,
Abstinence and « low-risk » consumption 1 year after the initiation of high-dose baclofen: a retrospective study among « high-risk » drinkers, Alcohol Alcohol. août, vol.47, issue.4, pp.439-481, 2012. ,
Suppression de la dépendance à l'alcool et de la consommation d'alcool par le baclofène à haute dose : un essai en ouvert, Ann MédPsychol Rev Psychiatr. mars, vol.168, issue.2, pp.159-62, 2010. ,
Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series, Alcohol Alcohol, vol.46, issue.6, pp.714-734, 2011. ,
Suppression of Alcohol Dependence Using Baclofen: A 2-Year Observational Study of 100 Patients. Front Psychiatry, vol.3, 2017. ,
The Use of Very High-Doses of Baclofen for the Treatment of AlcoholDependence: A Case Series. Front Psychiatry, vol.5, 2014. ,
Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study, Alcohol Alcohol. sept, vol.50, issue.5, pp.551-558, 2015. ,
Vérités et promesses d'un "nouveau" venu dans le traitement de l'alcoolo-dépendance, Alcoologie Addictologie. 15 juin, vol.32, issue.2, pp.119-143, 2010. ,
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, Lancet Lond Engl. 8 déc, vol.370, issue.9603, pp.1915-1937, 2007. ,
Guideline on the development of medicinal products for the treatment of alcohol dependence, 2010. ,
Review of the effectiveness of treatment for alcohol problems, 2006. ,
The hospital anxiety and depression scale, Acta Psychiatr Scand. juin, vol.67, issue.6, pp.361-70, 1983. ,
Evaluation of anxiety and depression among patients hospitalized on an internal medicine service, Ann Méd-Psychol. févr, vol.143, issue.2, pp.175-89, 1985. ,
The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability, J Psychosom Res, vol.69, issue.4, pp.371-379, 2010. ,
The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior, Alcohol Clin Exp Res. févr, vol.19, issue.1, pp.92-101, 1995. ,
Self-assessment questionnaire of alcoholic craving (ECCA Questionnaire: Behavior and Cognition in Relation to Alcohol: French translation and validation of the Obsessive-Compulsive Drinking Scale. L'Encéphale, vol.24, pp.426-460, 1998. ,
The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation, J Clin Epidemiol, vol.51, issue.11, pp.1013-1036, 1998. ,
, Niveaux de formation?Tableaux de l'Économie Française | Insee, 2017.
, chômage, revenus du travail-Insee RéférencesÉdition 2016?Emploi, chômage, revenus du travail | Insee
,
, Évolution de la population?Bilan démographique 2016 | Insee, 2017.
, État matrimonial légal des personnes selon le sexe en 2016 | Insee, 2017.
Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study, Alcohol Alcohol Oxf Oxfs. 1 juill, vol.52, issue.4, pp.439-485, 2017. ,
Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial, Eur Neuropsychopharmacol. déc, vol.26, issue.12, pp.1950-1959, 2016. ,
High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial, Eur Neuropsychopharmacol. 1 août, vol.25, issue.8, pp.1167-77, 2015. ,
, , 2017.
, Pendant quelle durée maximale avez-vous été abstinent ? ??????? mois ??????? années
, Quand cette période a-t-elle débuté ? ???????/?????????????
Selon vous, qu'est-ce qui vous a permis d'atteindre ce résultat ? ?????????? ,
,
, Nous allons maintenant vous poser des questions sur votre suivi médical